Breast MRI biopsy cancellation due to lesion nonvisualization. Issue 10 (13th September 2020)

• Record Type: Journal Article
• Authors: Ambinder, Emily B.; Myers, Kelly S.; Mullen, Lisa A.; Di Carlo, Philip; Philip, Mary; Fragomeni, Roberto; Nguyen, Derek; Oluyemi, Eniola
• Is Part Of: Breast journal. Volume 26:Issue 10(2020)
• Page Start: 2021
• Page End: 2025
• Publication Date: 2020-09-13
• Subjects: breast biopsy -- breast neoplasm -- magnetic resonance imaging; Breast -- Diseases -- Periodicals; Breast -- Cancer -- Periodicals; 618.19
• DOI: 10.1111/tbj.14044
• Languages: English
• ISSNs: 1075-122X

Abstract

Abstract: It is a clinical dilemma when a finding reported as suspicious on a breast MRI is not visualized at the time of a scheduled MRI‐guided breast biopsy. We retrospectively reviewed all canceled MRI‐guided biopsies at our institution between 6/1/2009 and 9/20/2019 and found a cancellation rate of 6.9% (72/1051). In one case, a mastectomy was performed after the canceled biopsy revealing a focus of DCIS in the same quadrant as the original finding (malignancy rate 2.1%). Our results support the current practice of 6‐month follow‐up MRI recommendation after a canceled MRI‐guided biopsy for lesion nonvisualization.